CIK: 0001738053
Total reported value
$503.6M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 18.45% | -2.38% | — | |
| 2 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 17.96% | -4.79% | EXIT | |
| 3 | ORTXUSD | Orchard Therapeutics PLC | Stock-Other | 11.91% | — | — | |
| 4 | 1T7 | Tricida INC | Stock-Other | 11.15% | -1.53% | EXIT | |
| 5 | ✓ | Obseva SA | Stock-Other | 10.67% | -5.35% | — | |
| 6 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 7.87% | -9.79% | EXIT | |
| 7 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 6.69% | -1.46% | EXIT | |
| 8 | KDMN | Kadmon Holdings INC | Stock-Other | 3.61% | — | — | |
| 9 | ✓ | Stock-Other | 2.97% | — | — | ||
| 10 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 2.63% | -0.24% | +87.27% | |
| 11 | PTGX | Protagonist Therapeutics INC | Stock-Other | 2.07% | -7.84% | — | |
| 12 | PTIEUR | Proteostasis Therapeutics In | Stock-Other | 2.00% | -0.12% | EXIT | |
| 13 | BLPHEUR | Bellerophon Therapeutics INC | Stock-Other | 1.33% | -0.69% | — | |
| 14 | ✓ | Gemphire Therapeutics INC | Stock-Other | 0.51% | — | — | |
| 15 | CNST | Constellation Pharmaceutical | Stock-Other | 0.19% | +23.27% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.4% | — | Unchanged |
| 2 | BCRX | Biocryst Pharmaceuticals INC | +0.3% | — | Unchanged |
| 3 | CNST | Constellation Pharmaceutical | -0.2% | — | Unchanged |
| 4 | BLPHEUR | Bellerophon Therapeutics INC | -0.5% | — | Unchanged |
| 5 | ✓ | Gemphire Therapeutics INC | -0.8% | — | Unchanged |
| 6 | KDMN | Kadmon Holdings INC | -2.4% | — | Unchanged |
| 7 | MRNSUSD | Marinus Pharmaceuticals INC | -2.5% | +87.27% | Add |
| 8 | 4XC1 | Kalvista Pharmaceuticals INC | -3% | — | Unchanged |
| 9 | 1T7 | Tricida INC | -3.9% | — | Unchanged |
| 10 | ✓ | Obseva SA | -5.1% | — | Unchanged |
| 11 | ORTXUSD | Orchard Therapeutics PLC | — | NEW | New buy |
| 12 | RARXEUR | Ra Pharmaceuticals INC | — | NEW | New buy |
| 13 | ✓ | Endocyte INC | — | EXIT | Sold out |
| 14 | ✓ | — | NEW | New buy | |
| 15 | PTGX | Protagonist Therapeutics INC | — | NEW | New buy |
| 16 | PTIEUR | Proteostasis Therapeutics In | — | NEW | New buy |
| 17 | APLSUSD | Apellis Pharmaceuticals INC | — | EXIT | Sold out |
| 18 | CCXIEUR | Chemocentryx INC | — | EXIT | Sold out |